GenoPalate

Milwaukee, United States Founded: 2016 • Age: 10 yrs
Personalized diet plans are offered based on genetic analysis.
Request Access

About GenoPalate

GenoPalate is a company based in Milwaukee (United States) founded in 2016 by Sherry Zhang.. GenoPalate has raised $15.41 million across 8 funding rounds from investors including Gener8tor and BrightStar Wisconsin Foundation. GenoPalate operates in a competitive market with competitors including Viome, Invitae, Color, Everlywell and Variant Bio, among others.

  • Headquarter Milwaukee, United States
  • Founders Sherry Zhang
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $15.41 M (USD)

    in 8 rounds

  • Latest Funding Round
    $3 M (USD), Series A

    Oct 03, 2024

  • Investors
    Gener8tor

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of GenoPalate
Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Hannah Pekarek
Product Manager
People
Frankie O’Brien
Clinical Dietitian
People
Hector Guillen
VP of Research & Analytics

Unlock access to complete

Funding Insights of GenoPalate

GenoPalate has successfully raised a total of $15.41M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 8
  • Last Round Series A — $3.0M
  • First Round

    (01 Jun 2017)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2024 Amount Series A - GenoPalate Valuation

investors

Oct, 2022 Amount Series A - GenoPalate Valuation

investors

Dec, 2020 Amount Series A - GenoPalate Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in GenoPalate

GenoPalate has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Gener8tor and BrightStar Wisconsin Foundation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Startups are accelerated via a 12-week program with funding support.
Founded Year Domain Location
Capital is provided to Wisconsin entrepreneurs for job creation.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by GenoPalate

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - GenoPalate

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Genopalate Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of GenoPalate

GenoPalate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viome, Invitae, Color, Everlywell and Variant Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Machine learning-based bioinformatics solutions for health insights are provided.
domain founded_year HQ Location
Home-based genetic tests for detecting diseases are provided to individuals.
domain founded_year HQ Location
Cancer care is delivered through a virtual clinic by Color.
domain founded_year HQ Location
At-home health tests for biomarkers, nutrition, and hormone analysis.
domain founded_year HQ Location
Personalized therapeutics are developed using genomic data for rare diseases.
domain founded_year HQ Location
Health management platform is provided for employers and insurers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Genopalate

Frequently Asked Questions about GenoPalate

When was GenoPalate founded?

GenoPalate was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is GenoPalate located?

GenoPalate is headquartered in Milwaukee, United States. It is registered at Milwaukee, Wisconsin, United States.

Who is the current CEO of GenoPalate?

Sherry Zhang is the current CEO of GenoPalate. They have also founded this company.

Is GenoPalate a funded company?

GenoPalate is a funded company, having raised a total of $15.41M across 8 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Jun 01, 2017.

What does GenoPalate do?

GenoPalate was founded in 2016 in Milwaukee, United States, and operates in the personalized nutrition sector. DNA test kits are provided for sample collection, which are analyzed using a proprietary algorithm. Reports with diet and food recommendations are generated from the results. A customized toolkit containing nutritional information and advice is supplied to consumers for ongoing use.

Who are the top competitors of GenoPalate?

GenoPalate's top competitors include Viome, Variant Bio and Segterra (InsideTracker).

Who are GenoPalate's investors?

GenoPalate has 2 investors. Key investors include Gener8tor, and BrightStar Wisconsin Foundation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available